Abstract
Purpose
The prime end of this study was to design a novel pH-sensitive as well as a PEGylated dendritic nanocarrier for both controllable and traceable gemcitabine delivery to cancerous cells. To accomplish this goal, we took advantage of a hybrid of nanoparticles including: mesoporous silica, graphene oxide and magnetite.
Methods
The nanocarrier was prepared in a multi-step synthesis route. First, magnetite mesoporous silica was deposited on the graphene oxide matrix. Then, polyamidoamine dendrimers (up to generation 1.5) with pentaethylene hexamine end groups were grafted on the surface of the nanoparticles. In order to enhance the biostability, and as the next step, the nanocarrier was modified by polyethylene glycol. Finally, these particles were functionalized by folic acid as tumor targeting agents.
Results
According to the dynamic light scattering results, the hydrodynamic diameter of magnetic mesoporous silica graphene oxide hybrid nanoparticle was 152 ± 3 nm, while for the supramolecular hybrid nanoparticles it was about 324 ± 12 nm. Attained through the adsorption branch, the average pore diameter of these nanoparticles was 7.6 nm. Zeta potential test indicated −27.1 mV value for hybrid nanoparticles and +7.35 mV for supramolecular hybrid nanoparticles. Besides, cytotoxicity assay showed enhanced cytotoxicity of epidermoid carcinoma cell line A431 in the presence of folate conjugated carriers. The maximum release occurred at the pH 5.5, because the dendritic structure was in the open state rather than compact state.
Conclusions
The enhanced cytotoxicity of the epidermoid carcinoma cell line A431 in the presence of folate conjugated carriers, confirmed the improved cancerous cells uptake. Also, the positive surface potential would be a good property for the biological applications because the inherent negative-charged surface of cell membranes facilitates the uptake of positive particles by electrostatic interactions.
Similar content being viewed by others
Abbreviations
- AFM:
-
Atomic force microscope
- APTS:
-
Aminopropyltriethoxysilane
- BET:
-
Brunauer–Emmett–Teller
- CTAB:
-
Cetyltrimethyl ammonium bromide
- DCC:
-
Dicylohexylcarbodiimide
- DLS:
-
Dynamic light scattering
- DMSO:
-
Dimethylsulfoxide
- EDA:
-
Ethylenediamine
- FA:
-
Folic acid
- FBS:
-
Fetal bovine serum
- Fe3O4@GO@mSiO2 :
-
Magnetic mesoporous silica coated graphene oxide
- FT-IR:
-
Fourier transform infrared
- GO:
-
Graphene oxide
- MTT:
-
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide
- PAMAM:
-
Polyamidoamine
- PBS:
-
Phosphate buffer saline
- PEG:
-
Polyethylene glycol
- TEM:
-
Transmission electron microscope
- TEOS:
-
Tetraethyl orthosilicate
- TGA:
-
Thermogravimetric analysis
- WAXD:
-
Wide angle X-ray diffraction
References
Wang ZM, Wang W, Coombs N, Soheilnia N, Ozin GA. Graphene oxide-periodic mesoporous silica sandwich nanocomposites with vertically oriented channels. ACS Nano. 2010;4:7437–50.
Tasciotti E, Liu XW, Bhavane R, Plant K, Leonard AD, Price BK, et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol. 2008;3:151–7.
Wang Y, Shi W, Song WS, Wang L, Liu XG, Chen J, et al. Tumor cell targeted delivery by specific peptide-modified mesoporous silica nanoparticles. J Mater Chem. 2012;22:14608–16.
Jiang H, Zeng X, Xi Z, Liu M, Li C, Li Z, et al. Improvement on controllable fabrication of streptavidin-modified three layer core-shell Fe3O4@SiO2@Au magnetic nanocomposites with low fluorescence background. J Biomed Nanotechnol. 2013;9:674–84.
Wang Y, Wang K, Zhao J, Liu X, Bu J, Yan X, et al. Multifunctional mesoporous silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma. J Am Chem Soc. 2013;135:4799–804.
Pourjavadi A, Tehrani ZM, Jokar S. Functionalized mesoporous silica-coated magnetic graphene oxide by polyglycerol-g-polycaprolactone with pH-responsive behavior: designed for targeted and controlled doxorubicin delivery. J Ind Eng Chem. 2015;28:45–53.
Doshi M. Dendrimer and its application. Int J Pharm Sci Rev Res. 2011;7:104–11.
El-Sayed M, Rhodes CA, Ginski M, Ghandehari H. Transport mechanism(s) of poly(amidoamine) dendrimers across Caco-2 cell monolayers. Int J Pharm. 2003;265:151–7.
Najlah M, D’Emanuele A. Crossing cellular barriers using dendrimer nanotechnologies. Curr Opin Pharmacol. 2006;6:522–7.
Duncan R, Malik N, Wiwattanapatapee R, Klopsch R, Lorenze K, Frey H, et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J Control Release. 2000;65:133–48.
Harris JM, Struck EC, Case MC, Paley MS, Yalpani M, Alstine VJM, et al. Synthesis and characterization of poly(ethylene glycol) derivatives. J Polym Sci Polym Chem Ed. 1984;22:341–52.
Bawa P, Pillay V, Choonara YE, du Toit LC. Stimuli-responsive polymers and their applications in drug delivery. Biomed Mater. 2009;4:022001.
Brando-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004;56:1649–59.
Low PS, Henne WA, Doorneweerd DD. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res. 2008;41:120–9.
Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev. 2002;54:675–93.
Sudimack J, Lee R. Targeted drug delivery via the folate receptor. J Adv Drug Deliv Rev. 2000;41:147–62.
Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, Nel AE, et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano. 2008;2:889–96.
Gu J, Fan W, Shimojima A, Okubo T. Organic–inorganic mesoporous nanocarriers integrated with biogenic ligands. Small. 2007;3:1740–4.
Pasqua L, Testa F, Aiello R, Cundari S, Nagy JB. Preparation of bifunctional hybrid mesoporous silica potentially useful for drug targeting. Microporous Mesoporous Mater. 2007;103:166–73.
Rosenholm JM, Meinander A, Peuhu E, Niemi R, Eriksson JE, Sahlgren C, et al. Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano. 2009;3:197–206.
Fehlauer F, Muench M, Smid EJ, Slotman B, Richter E, Van der Valk P, et al. Combined modality therapy of gemcitabine and irradiation on human glioma spheroids derived from cell lines and biopsy tissue. Oncol Rep. 2006;15:97–105.
Hummers WS, Offeman RE. Preparation of graphitic oxide. J Am Chem Soc. 1958;80:1339–9.
Chen CM, Yang QH, Yang YG, Lv W, Wen YF, Hou PX, et al. Self-assembled free-standing graphite oxide membrane. Adv Mater. 2009;21:3007–11.
Wang G, Yang S, Wei Z, Dong X, Wang H, Qi M. Facile preparation of poly(ε-caprolactone)/Fe3O4@graphene oxide superparamagnetic nanocomposites. Polym Bull. 2013;70:2359–71.
Yin P, Sun N, Deng C, Li Y, Zhang X, Yang P. Facile preparation of magnetic graphene double-sided mesoporous composites for the selective enrichment and analysis of endogenous peptides. Proteomics. 2013;13:2243–50.
Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, et al. A new class ofpolymers: starburst-dendritic macromolecules. Polym J. 1995;17:117–32.
Barrera C, Herrera AP, Bezares N, Fachini E, Olayo-Valles R, Hinestroza JP, et al. Effect of poly(ethylene oxide)-silane graft molecular weight on the colloidal properties of iron oxide nanoparticles for biomedical applications. J Colloid Interface Sci. 2012;377:40–50.
Pourjavadi A, Hosseini SH, Alizadeh M, Bennett C. Magnetic pH-responsive nanocarrier with long spacer length and high colloidal stability for controlled delivery of doxorubicin. Colloids Surf B: Biointerfaces. 2014;116:49–54.
Tang H, Guo J, Sun Y, Chang B, Ren Q, Yang W. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery. Int J Pharm. 2011;421:388–96.
Higuchi T. Mechanisms of sustained action mediation. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145–9.
Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci. 1961;50:874–5.
Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2012;64:163–74.
Fu YS, Chen HQ, Sun XQ, Wang X. Combination of cobalt ferrite and graphene: high performance and recyclable visible-light photocatalysis. Appl Catal B Environ. 2012;111:280–7.
Andersson J, Rosenholm J, Lindén M. Mesoporous silica: an alternative diffusion controlled drug delivery system. In: N. Ashammakhi, editor. Topics in Multifunctional Biomaterials and Devices. 2008.
ACKNOWLEDGMENTS AND DISCLOSURES
We are grateful to Miss. Mohadeseh Doroudian and Mr. Behzad Pourbadiei for the help in MTT assay.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pourjavadi, A., Tehrani, Z.M. & Moghanaki, A.A. Folate-Conjugated pH-Responsive Nanocarrier Designed for Active Tumor Targeting and Controlled Release of Gemcitabine. Pharm Res 33, 417–432 (2016). https://doi.org/10.1007/s11095-015-1799-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-015-1799-7